Skip to content

Restoration of Arm Function in People With High-level Tetraplegia

Personalised Approach to Restoration of Arm Function in People With High-level Tetraplegia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04102826
Enrollment
4
Registered
2019-09-25
Start date
2021-09-29
Completion date
2023-12-13
Last updated
2024-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Incomplete Spinal Cord Injury

Brief summary

Functional electrical stimulation (FES) has been used to activate paralysed muscles and restore movement after spinal cord injury and stroke. This technology involves the application of low-level electrical currents to the nerves and muscles to cause muscle contraction where the user's ability to achieve that through voluntary means has been lost. Providing control of muscle contraction in a coordinated way can mean that users are able once again to produce functional movements in otherwise paralysed limbs. Routine clinical use is limited to the prevention of drop foot in the lower limb following stroke and occasional therapeutic use in the hand and shoulder. Systems providing functional reach and grasp, however, have not achieved clinical or commercial success. This project aims to develop methods for personalising assistive technology to restore arm function in people with high-level spinal cord injury. The investigators will use a combination of electrical stimulation to elicit forces in muscles no longer under voluntary control, and mobile arm supports to compensate for insufficient muscle force where necessary. The investigators will use computational models specific to an individual's functional limitations to produce patient-specific interventions. The project will be in three phases: building a model to predict the effects of electrical stimulation on a paralysed arm with arm support, development of methodologies using this model to optimise the arm support and stimulation system, and testing of stimulation controllers designed using this approach.

Interventions

Functional electrical stimulation combined with mobile arm support to restore upper limb function.

Sponsors

Engineering and Physical Sciences Research Council, UK
CollaboratorOTHER
Keele University
CollaboratorOTHER
Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with mid- to high-level spinal cord injury resulting in partial or full paralysis of the upper limb will be eligible for inclusion in the study. In addition, they must be: * Able to give informed consent; * Able to remain comfortably seated with provision of trunk stability; * Medically stable and at least six weeks from injury; and * Have sufficient passive range of motion without discomfort.

Exclusion criteria

* Have orthopaedic implants across or between electrode sites; * Have active cardiac implant; * Have poor skin conditions, scar or carcinogenic tissue at site of stimulation; * Have uncontrolled pain; * Have uncontrolled epilepsy; * Have skin reactions to electrodes; * Have open wounds or injuries; and * Are pregnant or planning for a pregnancy.

Design outcomes

Primary

MeasureTime frameDescription
Change in Canadian Occupational Performance Measure (COPM)At baseline and at study completion for each participant. Study completion will be up to 6 months after the baseline measurement.The COPM is a questionnaire based assessment of performance and satisfaction of functional tasks. The COPM measures an individuals self-perception of occupational performance over time. This is a 10 point scale, with 1 indicating poor performance and low satisfaction, and 10 indicating very good performance and high satisfaction. The scale is applied to up to 5 problems identified by an individual that affect their everyday life. An average score is then calculated.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026